These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

138 related items for PubMed ID: 10831671

  • 1. Hyperlipidaemia and post-heparin lipase activities in renal transplant recipients treated with sirolimus or cyclosporin A.
    Massy ZA, De Bandt JP, Morelon E, Thevenin M, Lacour B, Kreis H.
    Nephrol Dial Transplant; 2000 Jun; 15(6):928. PubMed ID: 10831671
    [No Abstract] [Full Text] [Related]

  • 2. Dislipidemia at different immunosuppressive protocols.
    Zezina L, Rosental R.
    Transplant Proc; 1994 Dec; 26(6):3223. PubMed ID: 7998123
    [No Abstract] [Full Text] [Related]

  • 3. Effect of conversion from cyclosporine to tacrolimus on lipid profiles in renal transplant recipients.
    Colak T, Karakayali H, Yagmurdur MC, Moray G.
    Transplant Proc; 2002 Sep; 34(6):2081-2. PubMed ID: 12270321
    [No Abstract] [Full Text] [Related]

  • 4. Sirolimus changes lipid concentrations and lipoprotein metabolism in kidney transplant recipients.
    Morrisett JD, Abdel-Fattah G, Kahan BD.
    Transplant Proc; 2003 May; 35(3 Suppl):143S-150S. PubMed ID: 12742487
    [Abstract] [Full Text] [Related]

  • 5. Changes in serum lipid and (APO) lipoprotein levels in renal transplant recipients.
    Ishii T, Imanishi M, Nishioka T, Kunikata S, Akiyama T, Kurita T.
    Transplant Proc; 1998 Nov; 30(7):3021-2. PubMed ID: 9838331
    [No Abstract] [Full Text] [Related]

  • 6. Lipid profile in renal transplant recipients under various immunosuppressive regimens.
    Montagnino G, Tarantino A, Aroldi A, Banfi G, Cesana B, Ponticelli C.
    Transplant Proc; 1994 Oct; 26(5):2634-6. PubMed ID: 7940821
    [No Abstract] [Full Text] [Related]

  • 7. Effects of fish oil in cyclosporine-treated renal transplant recipients.
    Santos J, Queirós J, Silva F, Cabrita A, Rodrigues A, Henriques AC, Sarmento AM, Pereira MC, Guimarães S.
    Transplant Proc; 2000 Dec; 32(8):2605-8. PubMed ID: 11134724
    [No Abstract] [Full Text] [Related]

  • 8. Impact of tacrolimus on hyperlipidemia after renal transplantation: a Japanese single center experience.
    Manu M, Tanabe K, Tokumoto T, Ishikawa N, Shimizu T, Okuda H, Ito S, Shimmura H, Inui M, Harano M, Shiroyanagi Y, Yagisawa T, Fuchinoue S, Toma H.
    Transplant Proc; 2000 Nov; 32(7):1736-8. PubMed ID: 11119912
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Low-dose lovastatin in hyperlipidemic kidney graft recipients with cyclosporine A.
    Traindl O, Reading S, Franz M, Falger S, Klauser R, Gisinger J, Widhalm K, Kovarik J.
    Transplant Proc; 1992 Dec; 24(6):2745-7. PubMed ID: 1465924
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Cyclosporine to tacrolimus: effect on hypertension and lipid profiles in renal allografts.
    Copley JB, Staffeld C, Lindberg J, Hansen A, Bailey C, Anand R, Van Veldhuisen P.
    Transplant Proc; 1998 Jun; 30(4):1254-6. PubMed ID: 9636510
    [No Abstract] [Full Text] [Related]

  • 13. Sirolimus-induced hyperlipidaemia in liver transplant recipients is not dose-dependent.
    Firpi RJ, Tran TT, Flores P, Nissen N, Colquhoun S, Shackleton C, Martin P, Vierling JM, Poordad FF.
    Aliment Pharmacol Ther; 2004 May 01; 19(9):1033-9. PubMed ID: 15113371
    [Abstract] [Full Text] [Related]

  • 14. Effect of pancreas transplantation on lipoprotein lipase, postprandial lipemia, and HDL cholesterol.
    Föger B, Königsrainer A, Palos G, Brandstätter E, Ritsch A, König P, Miesenböck G, Lechleitner M, Margreiter R, Patsch JR.
    Transplantation; 1994 Oct 27; 58(8):899-904. PubMed ID: 7940733
    [Abstract] [Full Text] [Related]

  • 15. Apolipoprotein E genotypes as predictors of high-risk groups for developing hyperlipidemia in kidney transplant recipients undergoing sirolimus treatment.
    Maluf DG, Mas VR, Archer KJ, Yanek K, King A, Ferreira-Gonzalez A, Fisher RA, Posner M.
    Transplantation; 2005 Dec 27; 80(12):1705-11. PubMed ID: 16378065
    [Abstract] [Full Text] [Related]

  • 16. Conversion to tacrolimus in hyperlipidemic patients.
    Friemann S, Stopp K, Christ B, Weimer R, Padberg W, Ernst W.
    Transplant Proc; 1999 Nov 27; 31(7A):41S-43S. PubMed ID: 10576042
    [No Abstract] [Full Text] [Related]

  • 17. Hyperlipidemia in stable renal transplant recipients.
    Ong-Ajyooth L, Sirisalee K, Shayakul C, Vareesangthip K, Vasuvattakul S, Chirawong P, Vanichakarn S, Nimmannit S, Ong-Ajyooth S, Nilwarangkur S.
    Transplant Proc; 1994 Aug 27; 26(4):2062-4. PubMed ID: 8066670
    [No Abstract] [Full Text] [Related]

  • 18. Effects of cerivastatin on lipid profiles, lipid peroxidation and platelet and endothelial activation in renal transplant recipients.
    Caillard S, Leray C, Kunz K, Gachet C, Offner M, Wiesel ML, Hannedouchte T, Cazenave JP, Moulin B.
    Transplant Proc; 2000 Dec 27; 32(8):2787-8. PubMed ID: 11134806
    [No Abstract] [Full Text] [Related]

  • 19. Apolipoprotein CIII is upregulated by anticalcineurins and rapamycin: implications in transplantation-induced dyslipidemia.
    Tur MD, Garrigue V, Vela C, Dupuy AM, Descomps B, Cristol JP, Mourad G.
    Transplant Proc; 2000 Dec 27; 32(8):2783-4. PubMed ID: 11134804
    [No Abstract] [Full Text] [Related]

  • 20. Influence of cyclosporin, tacrolimus and rapamycin on renal function and arterial hypertension after renal transplantation.
    Morales JM, Andres A, Rengel M, Rodicio JL.
    Nephrol Dial Transplant; 2001 Dec 27; 16 Suppl 1():121-4. PubMed ID: 11369839
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.